184 related articles for article (PubMed ID: 36251553)
1. Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018.
Person MK; Cook R; Bradley JS; Hupert N; Bower WA; Hendricks K
Clin Infect Dis; 2022 Oct; 75(Suppl 3):S392-S401. PubMed ID: 36251553
[TBL] [Abstract][Full Text] [Related]
2. Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
Kennedy JL; Bulitta JB; Chatham-Stephens K; Person MK; Cook R; Mongkolrattanothai T; Shin E; Yu P; Negron ME; Bower WA; Hendricks K
Clin Infect Dis; 2022 Oct; 75(Suppl 3):S379-S391. PubMed ID: 36251546
[TBL] [Abstract][Full Text] [Related]
3. CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.
Bower WA; Yu Y; Person MK; Parker CM; Kennedy JL; Sue D; Hesse EM; Cook R; Bradley J; Bulitta JB; Karchmer AW; Ward RM; Cato SG; Stephens KC; Hendricks KA
MMWR Recomm Rep; 2023 Nov; 72(6):1-47. PubMed ID: 37963097
[TBL] [Abstract][Full Text] [Related]
4. Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review.
Hesse EM; Godfred-Cato S; Bower WA
Clin Infect Dis; 2022 Oct; 75(Suppl 3):S432-S440. PubMed ID: 36251559
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features of Patients Hospitalized for All Routes of Anthrax, 1880-2018: A Systematic Review.
Hendricks K; Person MK; Bradley JS; Mongkolrattanothai T; Hupert N; Eichacker P; Friedlander AM; Bower WA
Clin Infect Dis; 2022 Oct; 75(Suppl 3):S341-S353. PubMed ID: 36251560
[TBL] [Abstract][Full Text] [Related]
6. Antitoxin Treatment of Inhalation Anthrax: A Systematic Review.
Huang E; Pillai SK; Bower WA; Hendricks KA; Guarnizo JT; Hoyle JD; Gorman SE; Boyer AE; Quinn CP; Meaney-Delman D
Health Secur; 2015; 13(6):365-77. PubMed ID: 26690378
[TBL] [Abstract][Full Text] [Related]
7. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.
Hendricks KA; Wright ME; Shadomy SV; Bradley JS; Morrow MG; Pavia AT; Rubinstein E; Holty JE; Messonnier NE; Smith TL; Pesik N; Treadwell TA; Bower WA;
Emerg Infect Dis; 2014 Feb; 20(2):. PubMed ID: 24447897
[TBL] [Abstract][Full Text] [Related]
8. Treating Anthrax-Induced Meningitis in Rabbits.
Ben-Shmuel A; Glinert I; Sittner A; Bar-David E; Schlomovitz J; Brosh T; Kobiler D; Weiss S; Levy H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661872
[TBL] [Abstract][Full Text] [Related]
9. Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident.
Bower WA; Hendricks K; Pillai S; Guarnizo J; Meaney-Delman D;
MMWR Recomm Rep; 2015 Dec; 64(4):1-22. PubMed ID: 26632963
[TBL] [Abstract][Full Text] [Related]
10. Management of anthrax meningitis.
Sejvar JJ; Tenover FC; Stephens DS
Lancet Infect Dis; 2005 May; 5(5):287-95. PubMed ID: 15854884
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature Review.
Pillai SK; Huang E; Guarnizo JT; Hoyle JD; Katharios-Lanwermeyer S; Turski TK; Bower WA; Hendricks KA; Meaney-Delman D
Health Secur; 2015; 13(6):355-64. PubMed ID: 26623698
[TBL] [Abstract][Full Text] [Related]
12. The prophylaxis and treatment of anthrax.
Brook I
Int J Antimicrob Agents; 2002 Nov; 20(5):320-5. PubMed ID: 12431866
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019.
Maxson T; Kongphet-Tran T; Mongkolrattanothai T; Travis T; Hendricks K; Parker C; McLaughlin HP; Bugrysheva J; Ambrosio F; Michel P; Cherney B; Lascols C; Sue D
Clin Infect Dis; 2022 Oct; 75(Suppl 3):S373-S378. PubMed ID: 36251548
[TBL] [Abstract][Full Text] [Related]
14. Identifying Meningitis During an Anthrax Mass Casualty Incident: Systematic Review of Systemic Anthrax Since 1880.
Katharios-Lanwermeyer S; Holty JE; Person M; Sejvar J; Haberling D; Tubbs H; Meaney-Delman D; Pillai SK; Hupert N; Bower WA; Hendricks K
Clin Infect Dis; 2016 Jun; 62(12):1537-1545. PubMed ID: 27025833
[TBL] [Abstract][Full Text] [Related]
15. Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review.
Parker CM; Karchmer AW; Fisher MC; Muhammad KM; Yu PA
Clin Infect Dis; 2022 Oct; 75(Suppl 3):S417-S431. PubMed ID: 36251549
[TBL] [Abstract][Full Text] [Related]
16. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis.
Deziel MR; Heine H; Louie A; Kao M; Byrne WR; Basset J; Miller L; Bush K; Kelly M; Drusano GL
Antimicrob Agents Chemother; 2005 Dec; 49(12):5099-106. PubMed ID: 16304178
[TBL] [Abstract][Full Text] [Related]
17. Obiltoxaximab (Anthim) for inhalation anthrax.
Med Lett Drugs Ther; 2018 Sep; 60(1555):150-151. PubMed ID: 30383733
[No Abstract] [Full Text] [Related]
18. Risk Factors for Severe Cutaneous Anthrax in a Retrospective Case Series and Use of a Clinical Algorithm to Identify Likely Meningitis and Evaluate Treatment Outcomes, Kyrgyz Republic, 2005-2012.
Kutmanova A; Zholdoshev S; Roguski KM; Sholpanbay Uulu M; Person MK; Cook R; Bugrysheva J; Nadol P; Buranchieva A; Imanbaeva L; Dzhangazieva A; Bower WA; Hendricks K
Clin Infect Dis; 2022 Oct; 75(Suppl 3):S478-S486. PubMed ID: 36251556
[TBL] [Abstract][Full Text] [Related]
19. Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis.
Bradley JS; Bulitta JB; Cook R; Yu PA; Iwamoto C; Hesse EM; Chaney D; Yu Y; Kennedy JL; Sue D; Karchmer AW; Bower WA; Hendricks K
Clin Infect Dis; 2024 Jun; 78(6):1451-1457. PubMed ID: 38412060
[TBL] [Abstract][Full Text] [Related]
20. Pediatric anthrax: implications for bioterrorism preparedness.
Bravata DM; Wang E; Holty JE; Lewis R; Wise PH; Nayak S; Liu H; McDonald KM; Owens DK
Evid Rep Technol Assess (Full Rep); 2006 Aug; (141):1-48. PubMed ID: 17764208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
